Table 1.
Ratios used to estimate the incidence of cases of non-invasive infections, France 2012
| Body sites | PPS ratio | Ratios from the literature | |
|---|---|---|---|
| Low value | High value | ||
| No. MRSA urinary tract infections/No. MRSA invasive infections | 0.98 [7] | 0.75 [11] | 2.30 [12] |
| No. MRSA respiratory infections/No. MRSA invasive infections | 2.37 [7] | 1.25 [11] | 2.50 [12] |
| No. MRSA skin and soft tissue infections and surgical site infections/No. MRSA invasive infections | 4.17 [7] | 4.90 [12] | 5.25 [11] |
| No. MRSA bone and joint infections/No. MRSA invasive infections | 0.79 [7] | b | 1.38 [12] |
| No. GRE urinary tract infections/No. GRE invasive infections | 4.33 [7] | 2.33 [13] | 3.44 [14] |
| No. GRE gastrointestinal tract infections /No. GRE invasive infections | 2.65 [7] | 1.89 [14] | b |
| No. GRE skin and soft tissue infections and surgical site infections/No. GRE invasive infections | 1.46 [7] | 4.67 [14] | 5.00 [13] |
| No. 3GC-R E. coli urinary tract infections/No. 3GC-R E. coli invasive infections | 5.50 [7] | 2.30 [13] | b |
| No. 3GC-R E. coli respiratory tract infections/No. 3GC-R E. coli invasive infections | 1.08 [7] | b | 2.50 [13] |
| No. 3GC-R E. coli skin and soft tissue infections and surgical site infections/No. 3GC-R E. coli invasive infections | 1.37 [7] | b | 4.90 [13] |
| No. 3GC-R K. pneumoniae urinary tract infections/No. 3GC-R K. pneumoniae invasive infections | 2.90 [7] | 1.19 [15] | 2.30 [13] |
| No. 3GC-R K. pneumoniae respiratory tract infections/No. 3GC-R K. pneumoniae invasive infections | 2.55 [7] | 1.19 [15] | 2.50 [13] |
| No. 3GC-R K. pneumoniae skin and soft tissue infections and surgical site infections/No. 3GC-R K. pneumoniae invasive infections | 0.82 [7] | 0.33 [15] | 4.90 [13] |
| No. CR K. pneumoniae urinary tract infections/No. CR K. pneumoniae invasive infections | 2.71 [7] | 3.00 [16] | 3.10 [17] |
| No. CR K. pneumoniae respiratory tract infections/No. CR K. pneumoniae invasive infections | 3.10 [7] | 0.42 [17] | 1.60 [16] |
| No. CR K. pneumoniae skin and soft tissue infections and surgical site infections/No. CR K. pneumoniae invasive infections | 0.44a | 0.28 [17] | 0.60 [16] |
| No. CR P. aeruginosa urinary tract infections/No. CR P. aeruginosa invasive infections | 2.11 [7] | b | 11.30 [15] |
| No. CR P. aeruginosa respiratory tract infections/No. CR P. aeruginosa invasive infections | 10.99 [7] | b | 16.00 [15] |
| No. CR P. aeruginosa skin and soft tissue infections and surgical site infections/No. CR P. aeruginosa invasive infections | 3.07 [7] | b | 4.67 [15] |
| No. CR Acinetobacter urinary tract infections/No. CR Acinetobacter invasive infections | 0.58a | 0.32 [18] | 0.83 [17] |
| No. CR Acinetobacter respiratory tract infections/No. CR Acinetobacter invasive infections | 4.64 [7] | 1.21 [18] | 3.83 [17] |
| No. CR Acinetobacter skin and soft tissue infections and surgical site infections/No. CR Acinetobacter invasive infections | 0.73a | 0.29 [18] | 1.17 [17] |
ano 2012 PPS data for these infections because the prevalence of these MDRB is too low in France; the ratio value applied is the mean value of the 2 ratios from the literature
bno data in the literature for these infections; the value of the 2012 PPS ratio was applied